2020
DOI: 10.1111/xen.12669
|View full text |Cite
|
Sign up to set email alerts
|

Selection of a novel AAV2/TNFAIP3 vector for local suppression of islet xenograft inflammation

Abstract: Background Neonatal porcine islets (NPIs) can restore glucose control in mice, pigs, and non‐human primates, representing a potential abundant alternative islet supply for clinical beta cell replacement therapy. However, NPIs are vulnerable to inflammatory insults that could be overcome with genetic modifications. Here, we demonstrate in a series of proof‐of‐concept experiments the potential of the cytoplasmic ubiquitin‐editing protein A20, encoded by the TNFAIP3 gene, as an NPI cytoprotective gene. Methods We… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(15 citation statements)
references
References 71 publications
0
15
0
Order By: Relevance
“…Intact porcine pancreases (n = 23 female and n = 25 male) were excised from anesthetized 1 to 3 days old Duroc-Landrace neonatal piglets from the University of Alberta Swine Research Centre. 1,6,[33][34][35] During excision, the CL and bridge were dissected from the intestine, the SL was detached from the spleen and the DL was dissected from the duodenum by severing the duct (Figure 1A and B). To examine gross morphology, the whole pancreas (n = 4 female and n = 4 male) and dissected lobes were weighed, then assessed for total cellular insulin content as previously described.…”
Section: Neonatal Porcine Pancreas Procurement and Assessmentmentioning
confidence: 99%
See 3 more Smart Citations
“…Intact porcine pancreases (n = 23 female and n = 25 male) were excised from anesthetized 1 to 3 days old Duroc-Landrace neonatal piglets from the University of Alberta Swine Research Centre. 1,6,[33][34][35] During excision, the CL and bridge were dissected from the intestine, the SL was detached from the spleen and the DL was dissected from the duodenum by severing the duct (Figure 1A and B). To examine gross morphology, the whole pancreas (n = 4 female and n = 4 male) and dissected lobes were weighed, then assessed for total cellular insulin content as previously described.…”
Section: Neonatal Porcine Pancreas Procurement and Assessmentmentioning
confidence: 99%
“…Immunostaining and histological assessment was performed on 5 μm paraffin sections from each lobe as previously described. 1,6,[33][34][35] Primary antibodies included; insulin (IR00261-2; Agilent, Santa Clara CA, USA), proliferating cell nuclear antigen (PCNA; M0879; Agilent), cytokeratin 7 (CK-7; M701801-2; Agilent), somatostatin (SOM) (A0566; Agilent), pancreatic polypeptide (PPP) (A0619; Agilent), glucagon (G2654; MilliporeSigma, Oakville ON, Canada), pancreatic duodenal homeobox 1 (PDX1; ab47267; AbCAM, Cambridge, MA USA), PCNA For immunofluorescence, AlexaFluor conjugates were cover slipped with ProlongGold Anti-Fade with 4' ,6-diamidino-2-phenylindole (DAPI;ThermoFisher). Positive controls were new born pig pancreas sections and negative controls were sections incubated with secondary antibodies alone without primary antibody staining.…”
Section: Neonatal Porcine Pancreas Procurement and Assessmentmentioning
confidence: 99%
See 2 more Smart Citations
“…Functional studies on the A20 enzyme have shown that it is a major regulator of the inflammatory cascade that occurs by inhibiting NF‐κB activation and forced expression on mouse or human islets does not impair insulin secretion 52,53 . To validate the use of A20 in porcine NICCs, Grey's group developed a series of recombinant adenoviral vectors that expressed A20 and they transduced these into NICCs and measured their suppressive abilities and transduction efficiency 54 . Twenty‐four hours post forced expression of A20 on NICCs resulted in reduced IκBα degradation and phosphorylation as well as the suppression of islet inflammatory mRNAs such as Cxcl10, Icam1, Il1b, and Il6.…”
Section: Modification Of the Donor Or Treatments To Enhance Graft Survivalmentioning
confidence: 99%